CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 1 of the 19 sources its claims cite were checked for support.

Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Open access
Clutter, W E, Bier, D M, Shah, S D, Cryer, P E · 1980 · Journal of Clinical Investigation

Abstract

To determine the plasma epinephrine thresholds for its metabolic and hemodynamic actions and plasma epinephrine metabolic clearance rates, 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min were performed in each of six normal human subjects. These 30 infusions resulted in steady-state plasma epinephrine concentrations ranging from 24 to 1,020 pg/ml. Plasma epinephrine thresholds were 50-100 pg/ml for increments in heart rate, 75-125 pg/ml for increments in blood glycerol and systolic blood pressure, 150-200 pg/ml for increments in plasma glucose (the resultant of increments in glucose production and decrements in glucose clearance), blood lactate, blood beta-hydroxybutyrate, and diastolic blood pressure, and greater than 400 pg/ml for early decrements in plasma insulin. Changes in blood alanine, plasma glucagon, plasma growth hormone, and plasma cortisol were not detected. At steady-state plasma epinephrine concentrations of 24-74 pg/ml, values overlapping the basal normal range, the mean (+/-SE) plasma metabolic clearance rate of epinephrine was 52 +/- 4 ml x min-1 x kg-1; this value rose to 89 +/- 6 ml x min-1 x kg-1 (P less than 0.01) at steady-state epinephrine concentrations of 90-1,020 pg/ml. We conclude that in human subjects: (a) the plasma epinephrine thresholds for its hemodynamic and metabolic actions lie within the physiologic range, (b) epinephrine and norepinephrine accelerate their own metabolic clearance, and (c) epinephrine is 10 times more potent than norepinephrine.

Overview

CoChat Summary

TL;DR

In six normal human subjects, graded epinephrine infusions showed that hemodynamic and metabolic thresholds occur within the physiologic plasma epinephrine range. The study also found that epinephrine accelerates its own metabolic clearance and is about 10 times more potent than norepinephrine.

Key findings

  • Across 30 infusions, steady-state plasma epinephrine concentrations ranged from 24 to 1,020 pg/ml. Thresholds were 50–100 pg/ml for heart-rate increments; 75–125 pg/ml for systolic blood pressure and blood glycerol increments; 150–200 pg/ml for plasma glucose, glucose production, glucose clearance, blood lactate, blood β-hydroxybutyrate, and diastolic blood pressure changes; and >400 pg/ml for early plasma insulin decrements. No significant changes were detected in blood alanine, plasma glucagon, growth hormone, or cortisol.
  • Plasma epinephrine metabolic clearance rate was 52±4 ml·min⁻¹·kg⁻¹ at steady-state epinephrine concentrations of 24–74 pg/ml, overlapping the basal normal range, and rose to 89±6 ml·min⁻¹·kg⁻¹ at 90–1,020 pg/ml (P < 0.01), an approximately 70% increase.
  • From earlier norepinephrine data, plasma norepinephrine metabolic clearance rate was 25±4 ml·min⁻¹·kg⁻¹ at 229–345 pg/ml and 39±3 ml·min⁻¹·kg⁻¹ at higher levels (P < 0.02), suggesting catecholamines accelerate their own clearance.
  • Epinephrine thresholds for direct metabolic and hemodynamic effects (<200 pg/ml) were about 10% of previously determined norepinephrine thresholds (1,500–2,000 pg/ml), indicating epinephrine is ~10-fold more potent.

Methods

  • Six normal subjects (five men, one woman) each received five 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 μg/min after an overnight fast, supine, with infusions separated by at least 1 wk.
  • Plasma epinephrine and norepinephrine were measured by a single isotope derivative method; glucose by glucose oxidase; insulin, glucagon, and growth hormone by radioimmunoassay; cortisol by competitive protein binding; lactate, alanine, β-hydroxybutyrate, and glycerol by microfluorometric enzymatic techniques. Glucose kinetics used a primed continuous infusion of [6,6-²H₂]glucose with Steele’s equations for nonsteady-state conditions.
  • Plasma epinephrine metabolic clearance rate was calculated as measured infusion rate divided by the difference between steady-state and basal plasma epinephrine. Thresholds were estimated by inspection of semilogarithmic plots, extending regression lines through changed data points to the line of no change, and tended to be confirmed by nonlinear least squares regression.

Limitations

  • The paper states that the metabolic clearance calculation assumes basal endogenous epinephrine release continues during infusion; if endogenous release ceases, the calculation overestimates clearance, especially at lower steady-state concentrations. It also states that extremity epinephrine uptake may cause overestimation of epinephrine clearance and underestimation of norepinephrine clearance.
  • The paper states that threshold estimates were obtained by inspection and extrapolation of the central linear portion of sigmoidal dose-response curves, providing a maximum estimate; nonlinear least squares regression tended to confirm these values.
  • Evident from the text: the sample was small (six normal subjects, five men and one woman), and the study examined only normal human subjects, so findings may not generalize to women, other populations, or pathophysiologic states. The authors also note one discrepancy with earlier studies: they did not observe an increase in plasma glucagon during epinephrine infusions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci109840

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

1 Valid · 0 Not valid · 10 Not checked · 36 Own results and interpretations

32 more claims

Create a free account to see all 47 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 7
  • It may state two separate claims as one. 5

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 577

Metadata

Authors
Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E.
Affiliations
Washington University in St. Louis (US)
Venue
Journal of Clinical Investigation
Published
1980-07-01
Volume
66
Issue
1
Pages
94-101
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2133884882
Cited by
576
References
31
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
FWCI
29.70
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
epinephrine, norepinephrine, heart rate, blood pressure, blood glucose, blood lactate, beta-hydroxybutyrate, insulin, hemodynamic effects, metabolic effects, dose-response relationship
MeSH terms
Adult, Blood Glucose, Blood Pressure, Dose-Response Relationship, Drug, Epinephrine, Female, Glucagon, Heart Rate, Humans, Insulin, Kinetics, Male, Metabolic Clearance Rate, Norepinephrine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.